| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Revenue | $6.5M | +16.0% |
| Cost of Revenue | $754K | +37.5% |
| Gross Profit | $5.7M | +13.6% |
| R&D Expense | $791K | -29.4% |
| SG&A Expense | $14.6M | -18.1% |
| Operating Income | -$8.8M | +30.6% |
| Interest Expense | $398K | +949.9% |
| Pre-tax Income | -$8.9M | +30.3% |
| Net Income | -$8.9M |
| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $55K | -47.1% |
| Inventory | $249K | +5.8% |
| Current Assets | $4.4M | +744.2% |
| Total Assets | $6.2M | +220.8% |
| Current Liabilities | $4.1M | -1.5% |
| Total Liabilities | $4.3M | -6.2% |
| Stockholders' Equity | $1.9M | +170.9% |
| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.2M | -21.3% |
| Capital Expenditures | $825K | +66.3% |
| Investing Cash Flow | -$825K | -66.3% |
| Financing Cash Flow | $7.6M | +191.1% |
| Free Cash Flow | -$4.0M | -28.5% |
| +30.3% |